Search

Your search keyword '"Amant, Frederic"' showing total 923 results

Search Constraints

Start Over You searched for: Author "Amant, Frederic" Remove constraint Author: "Amant, Frederic"
923 results on '"Amant, Frederic"'

Search Results

1. Germline copy number variants and endometrial cancer risk

2. Prenatal cell-free DNA testing of women with pregnancy-associated cancer: a retrospective cross-sectional study

3. Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: A systematic review

5. Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy: a multicentre cohort study of the International Network on Cancer, Infertility, and Pregnancy

7. Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers

8. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers

12. High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer.

13. MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing.

15. Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study

16. Management of Rare Uterine Malignant Tumors

20. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer

22. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies

23. Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)

27. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

28. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)

29. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.

30. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.

31. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

32. Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

33. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study

35. PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors

36. Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial – ANZGOG 0903

37. Challenges and opportunities for proton therapy during pregnancy.

38. #447 Comparison between immunohistochemical-based model and genomic profiling in endometrial cancer molecular stratification: a propensity-matched survival analysis

39. Breast Cancer (Diagnosed) During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients

40. Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors

42. Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium

43. Common variants at 19p13 are associated with susceptibility to ovarian cancer.

Catalog

Books, media, physical & digital resources